<DOC>
	<DOCNO>NCT02374723</DOCNO>
	<brief_summary>Constructs make cross-linked Human Recombinant Collagen type III use instead human donor cornea 6 patient Deep anterior lamellar cornea graft . Six patient serve control receive human donor cornea use surgical technique . The twelve patient recruit local wait list patient undergoing corneal grafting . If patient meet inclusion criterion agree participate following oral write consent , randomize either group . The patient follow 12 month document OCT , In Vivo Confocal Microscopy , slit lamp photography . The study plan safety study initial efficacy documentation .</brief_summary>
	<brief_title>Evaluation Biosynthetic Constructs Replace Donor Corneas</brief_title>
	<detailed_description>12 patient recruited waitinglist corneal transplantation.The age 18 year older capable make decision . Their medical history present medication reveiwed undergo thorough ophthalmological examination order find meet inclusion criterion create baseline value study . Their general health medication affect cornea ocular surface . The Eye healthy exception disease indication corneal grafting . The corneal endothelium healthy . Any opacification eye graft reach Descemets membrane . Visual acuity fellow eye good . If criterion meet patient recieve oral write information study . If agree participate randomize either recieve biosynthetic cornea ( 6 patient ) recieve donate cornea ( 6 patient ) . They schedule surgery within 2 week examination irrespective participate study . The surgery anterior deep lamellar use femtosecond laser patient cut . The laser cut wil do topical anaaestesi . The remain surgery either perform local oor general anaestesia accord patient wish . The diameter cut 7 mm diameter . The graft material punch diameter 7.25 mm . The thickness material 500 Âµm . An amniotic membrane place top biosynthetic material suture single stiches together graft.A bandage lens place . The donated cornea suture single 8 stiches . The biosynthetic cornea recieve topical antibiotic dexametasone 8 week suture , remnant amniotic membrane bandage lens remove . The donated cornea recieve topical dexametasone 5 month suture remove 6 month . The check-up Schedule 1 day,1,2 weeks,1 , ,2 month extra needed.The protocol check-ups descriptive exyes document slit lamp photography . Epitelialisation monitor fluorescein staining . At 3,6,9 and12 month extensive group . UCVA BSCVA measure also BCLCVA 12 month . Corrneal topography , thickness sensitivity , tear production Visante OCT slit- lamp photography perform . Tear sample take also form earlier check-ups proteomic analysis . In vivo confocal microscopy perform . The different examination exception present result quantify statistically analyse . The CRFs adverse report form fill computer form paper . The safety outcome criterion : Good engraftment , maintain integrity graft , epithelialisation , transparency , induced inflammation , induced vasculatisation . The preliminary efficacy criterion : UCVA , BSCVA BCLCVA</detailed_description>
	<mesh_term>Corneal Diseases</mesh_term>
	<criteria>Indication Deep anterior lamellar corneal transplantation . No topical Eye medication . No Eye disease indication corneal graft . No general disease might affect cornea . No general medication might affect cornea .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>improve</keyword>
	<keyword>vision</keyword>
</DOC>